By regulating cyclinD1, MMP9 and p27, knockdown of S100A7 reduces epithelial ovarian cancer (EOC) cell proliferation, migration and invasion, and enhances chemosensitivity to cisplatin. The gene discussed is S100A7; the disease is ovarian carcinoma.